Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Jun 27, 2024Material event · 8-KFiled by the company itself.Open the filing ↗
- Jan 16, 2024Material event · 8-KFiled by the company itself.Open the filing ↗
- Dec 18, 2023Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year37
SEC filings on record2896 flagged findings
Reported transactions (Form 4)—not covered
Corporate events (8-K)0
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
The 25 most recent filings (of 289)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Armistice Capital, LLC · 11.4% · event on Jun 30, 26 · amendment
- May 15, 26SCHEDULE 13G/A ↗Passive stake · Armistice Capital, LLC · 11.4% · event on Mar 31, 26 · amendment
- Feb 17, 26SCHEDULE 13G/A ↗Passive stake · Armistice Capital, LLC · 11.4% · event on Dec 31, 25 · amendment
- Aug 14, 25SCHEDULE 13G/A ↗Passive stake · Armistice Capital, LLC · 11.4% · event on Jun 30, 25 · amendment
- May 15, 25SCHEDULE 13G/A ↗Passive stake · Armistice Capital, LLC · 11.4% · event on Mar 31, 25 · amendment
- Feb 14, 25SCHEDULE 13G/A ↗Passive stake · Armistice Capital, LLC · 11.4% · event on Dec 31, 24 · amendment
- Nov 14, 24SC 13G/A ↗Passive stake · amendment
- Jun 27, 248-K ↗Current report · Significant agreement signed · Unregistered sale of shares
- Feb 14, 24SC 13G/A ↗Passive stake · amendment
- Feb 13, 24SC 13G/A ↗Passive stake · amendment
- Jan 16, 248-K ↗Current report · Shareholder vote results
- Dec 18, 23DEFA14A ↗Shareholder meeting and votes
- Dec 18, 238-K ↗Current report · Bylaws or fiscal year change
- Dec 15, 23DEFA14A ↗Shareholder meeting and votes
- Nov 6, 2310-Q ↗Quarterly report
- Nov 3, 238-K ↗Current report · Results
- Nov 3, 23DEFA14A ↗Shareholder meeting and votes
- Nov 3, 23DEF 14A ↗Shareholder meeting and votes
289 filings on record, the oldest from Mar 5, 18.
Listing the 25 most recent filings of the 289 on record.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Armistice Capital, LLC11.4%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 5 earlier filings
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Its sector and its market
Aridis Pharmaceuticals Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Aridis Pharmaceuticals Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Aridis Pharmaceuticals Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 289 documents on file, from Mar 5, 2018 to Aug 14, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.